Comparison of Circulating Tumor DNA Assays for Molecular Residual Disease Detection in Early-Stage Triple-Negative Breast Cancer.

Saved in:
Bibliographic Details
Title: Comparison of Circulating Tumor DNA Assays for Molecular Residual Disease Detection in Early-Stage Triple-Negative Breast Cancer.
Authors: Coakley M; Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom., Villacampa G; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom., Sritharan P; Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom., Swift C; Ralph Lauren Centre for Breast Cancer Research, London, United Kingdom., Dunne K; Ralph Lauren Centre for Breast Cancer Research, London, United Kingdom., Kilburn L; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom., Goddard K; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom., Pipinikas C; NeoGenomics Ltd, Glenn Berge Building, Babraham Research Park, Cambridge, United Kingdom., Rojas P; NeoGenomics Ltd, Glenn Berge Building, Babraham Research Park, Cambridge, United Kingdom., Emmett W; NeoGenomics Ltd, Glenn Berge Building, Babraham Research Park, Cambridge, United Kingdom., Hall P; University of Edinburgh, Edinburgh, United Kingdom., Harper-Wynne C; Maidstone Hospital, Maidstone and Tunbridge Wells NHS Trust, Maidstone, United Kingdom., Hickish T; University Hospitals Dorset NHS Foundation Trust, Bournemouth, United Kingdom., Macpherson I; The Beatson West of Scotland Cancer Centre, Glasgow., Okines A; Breast Unit, Royal Marsden Hospital, London, United Kingdom., Wardley A; Outreach Research & Innovation Group Ltd, Manchester, United Kingdom., Wheatley D; Royal Cornwall Hospitals NHS Trust, Truro, United Kingdom., Waters S; Velindre Cancer Centre, Velindre University NHS Trust, Cardiff, United Kingdom., Palmieri C; Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, United Kingdom., Winter M; Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Cutts RJ; Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom., Garcia-Murillas I; Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom., Bliss J; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom., Turner NC; Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom.; Ralph Lauren Centre for Breast Cancer Research, London, United Kingdom.; Breast Unit, Royal Marsden Hospital, London, United Kingdom.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Feb 16; Vol. 30 (4), pp. 895-903.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-3265
DOI:10.1158/1078-0432.CCR-23-2326